Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the full record of transactions filed by Gelone Steven P., Former President and Chief Operating Officer. Officer active across 1 company, notably Nabriva Therapeutics plc. In total, 43 disclosures have been published. History available since 30 April 2021. The latest transaction was disclosed on 29 January 2023 (Retenue fiscale). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Gelone Steven P.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3,483 shares@ US$0.4524.2% of flowOrdinary SharesSEC:0001104659-22-010533:0
25 of 43 declarations
About Gelone Steven P.
Gelone Steven P. is a former President and Chief Operating Officer. He is also a Director of Nabriva Therapeutics plc (XNAS), and the 43 filings on record span from 2021-05-04 to 2023-01-31; among the sampled recent filings, the most common transaction nature is Retenue fiscale, with amounts of EUR 1406.069674507202 and EUR 192.7590155151949 among the largest.